Corneal Ectasia Clinical Trial
Official title:
Risk Assessment for Corneal Ectasia Following Laser in Situ Keratomileusis
Ectasia after refractive surgery is a relatively rare complication which can lead to sight-threatening complications if not detected and treated in time. It is important to continue our quest to improve our methods of identifying absolute and relative risk factors of ectasia following various keratorefractive surgical procedures.
Surgical correction of refractive errors is becoming increasingly popular. In the 1990s, the
excimer laser revolutionized the field of corneal refractive surgery with PRK and LASIK,
refractive lenticule extraction (ReLEx) of intracorneal tissue using only a femtosecond
laser, and lately ReLEx smile (SMILE). The term LASIK (Laser in situ keratomileusis) was
first used in 1990 by Pallikaris, in which a microkeratome was used to cut a hinged corneal
flap, followed by excimer ablation of the stromal bed and flap repositioning . LASIK is known
to be a safe refractive surgical procedure, with good refractive efficacy and predictability
and is associated with rapid visual recovery with minimal risk of complications.
Most of complications are flap related and include a free cap, a button hole, an incomplete
cut, flap striae, interface debris, diffuse lamellar keratitis (DLK), and epithelial
ingrowth. Other complications include undercorrection, overcorrection, decentered ablation,
irregular ablation, and ectasia.
Corneal ectasia is a sight-threatening complication of laser refractive surgery characterized
by progressive steepening and thinning of the cornea.It is defined as progressive stromal
thinning and steepening of the cornea, resulting in refractive aberrations and visual
deterioration. The incidence of post- LASIK ectasia is estimated to be between 0.04% and
0.6%.Corneal ectasia has been observed to occur as early as 1 week and as late as several
years after LASIK.
The main purpose of assessing risk is to determine what group or groups of people present a
higher chance to develop post-LASIK ectasia. The development of postoperative ectasia varies
between LASIK centers and depends on the screening tools used to screen candidates, the
experience and technical skill of the surgeon, and the tools used during the surgery. Risk
factors for the development of post-LASIK ectasia include young age, a personal or family
history of keratoconus, forme fruste keratoconus (FFKC), high myopia, low-residual stromal
bed (RSB), and deep primary keratotomy resulting in a thick flap.
Although several risk factors have been identified for the likelihood of ectasia development
after keratorefractive surgeries, some cases have been reported to develop in an enigmatic
way, without the prescence of any of these risk factors.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03319082 -
Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery
|
||
Recruiting |
NCT02009709 -
Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2
|
Phase 1 | |
Recruiting |
NCT04094090 -
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia
|
Phase 2 | |
Completed |
NCT04405882 -
Cornea Ectasia Excimer Laser Treatment
|
||
Active, not recruiting |
NCT01464268 -
Transepithelial Corneal Collagen Crosslinking for Keratoconus and Corneal Ectasia
|
Phase 3 | |
Active, not recruiting |
NCT04763785 -
Development of a Keratoconus Detection Algorithm by Deep Learning Analysis and Its Validation on Eyestar Images
|
||
Recruiting |
NCT01325298 -
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
|
Phase 2 | |
Recruiting |
NCT04251143 -
Dresden Corneal Disease and Treatment Study
|
||
Active, not recruiting |
NCT01152541 -
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
|
Phase 3 | |
Recruiting |
NCT04905108 -
Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia
|
Phase 3 | |
Recruiting |
NCT04401865 -
Safety and Effectiveness of the PXL-Platinum 330 System
|
Phase 1/Phase 2 | |
Completed |
NCT05691335 -
Three Different Cross-linking Protocols for Treatment of Pediatric Keratoconus
|
N/A | |
Completed |
NCT04475900 -
Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
|
||
Recruiting |
NCT05027295 -
Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light
|
Phase 3 | |
Completed |
NCT03913338 -
Laser In-situ Keratomileusis With Crosslinking Compared to Conventional LASIK in Patients With High Myopia
|
N/A | |
Terminated |
NCT01459679 -
Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery
|
Phase 3 | |
Withdrawn |
NCT01643252 -
Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
|
Phase 3 | |
Active, not recruiting |
NCT04698590 -
Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism
|
N/A | |
Completed |
NCT04177082 -
Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
|
Phase 1 | |
Recruiting |
NCT06347900 -
Corneal Topographic Changes in Different Grades of OSA
|